Kinevant Sciences is a clinical-stage biopharmaceutical company dedicated to treating rare autoimmune diseases with significant unmet needs.

Biotechnology

Health Care

Life Sciences

Pharmaceutical

Kinevant Sciences

Kinevant Sciences' headquarters in New York, NY, United States

Cynthia Scott

Chuck Bradley

Laura Hathaway

Jill Denning

Eric Venker

Frank Torti

The Leadership Team at Kinevant Sciences is responsible for setting the strategic direction and vision of the company, overseeing key operational functions, and ensuring regulatory compliance in the development of innovative treatments for rare autoimmune diseases. This team, comprising the CEO, CFO, and senior vice presidents, collaborates to prioritize programs, allocate resources, and drive the overall mission of improving patient outcomes in areas of significant unmet need.

Leadership Team

The Finance Team at Kinevant Sciences plays a crucial role in managing the company's financial health and strategic planning. This team oversees budgeting, forecasting, and financial reporting, ensuring compliance with regulations while supporting the company's mission to advance treatments for rare autoimmune diseases. By analyzing financial data and managing resources, they enable informed decision-making and drive sustainable growth.

Finance Team

The Clinical Operations Team at Kinevant Sciences is responsible for the planning, execution, and management of clinical trials aimed at evaluating novel therapies for rare autoimmune diseases. This team ensures compliance with regulatory standards, oversees trial logistics, and collaborates closely with cross-functional teams to drive clinical development strategies that ultimately enhance patient access to innovative treatments.

Kinevant Sciences

Org chart

Board & advisors

Teams

Leadership Team

Finance Team

Clinical Operations Team

Offices

Kinevant Sciences

Org chart

Board & advisors

Teams

Leadership Team

Finance Team

Clinical Operations Team

Offices

Related companies